{"url_path":"/sec/phge/8-k/2026-07-02/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1739174/0001213900-26-075072-index.html","accession_number":"0001213900-26-075072","cik":"0001739174","ticker":"PHGE","issuer_name":"BiomX Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1739174/0001213900-26-075072-index.html","primary_entity_key":"0001739174","primary_entity_name":"BiomX Inc."},"word_count":305,"has_tables":true,"body_markdown":"false\n0001739174\n\n0001739174\n\n2026-07-01\n2026-07-01\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n** **\n\n**FORM 8-K**\n\n**CURRENT REPORT**\n\n \n\nPursuant to Section 13 or Section 15(d)\n\nof the Securities Exchange Act of 1934\n\n \n\nDate of Report (Date of earliest event reported):\nJuly 1, 2026\n\n** **\n\n**BIOMX INC.**\n\n*(Exact name of registrant as specified in its\ncharter)*\n\n* *\n\n Delaware\n \n001-38762\n \n82-3364020\n\n*(State or other jurisdiction of\nincorporation or organization)*\n \n*(Commission File Number)*\n \n*(IRS Employer\nIdentification Number)*\n\n \n\n850 New Burton Road, Suite 201, Dover, DE 19904\n\n*(Address of principal executive offices)*\n\n \n\n972 52 437 4900\n\n*(Registrant’s telephone number, including\narea code)*\n\n \n\nNot Applicable\n\n*(Former name or former address, if changed since\nlast report)*\n\n \n\nCheck the appropriate box below if the Form 8-K filing is intended\nto simultaneously satisfy the filing obligation of the registrant under any of the following provisions:\n\n \n\n☐\nWritten\ncommunications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n\n☐\nSoliciting\nmaterial pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n \n\n☐\nPre-commencement\ncommunications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n \n\n☐\nPre-commencement\ncommunications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n \n\n** ** **Title of each class**\n \n**Trading Symbol(s)**\n \n**Name of each exchange on which registered**\n\nCommon Stock, $0.0001 par value per share\n \nPHGE\n \nNYSE American\n\n \n\nIndicate by check mark whether the registrant is an emerging growth\ncompany as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.\n\n \n\nEmerging growth company ☐\n\n \n\nIf an emerging growth company, indicate by check mark if the registrant\nhas elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant\nto Section 13(a) of the Exchange Act. ☐"}